US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CAR-T Concept

1,327.27

-6.8198-0.51%

Number of Gainers:1

Number of Losers:1

Number of Flat:1

PE:- -

High:1,339.48

Open:1,339.40

Low:1,309.77

Close:1,334.09

Loading ...

Sui Ecosystem Token Continues to Surge, WAL Surges Over 16% in 24 Hours

US Health Secretary Reportedly Says 35 States to Join Pilot Program for Sickle Cell Disease Gene Therapies

MT Newswires Live

Gilead Shares Down 3.6% After Quarterly Revenue Miss

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gilead Shares Down 4.2% Premarket After Quarterly Revenue Miss

THOMSON REUTERS

Gilead : RBC Raises Target Price to $92 From $89

THOMSON REUTERS

Gilead Sciences (GILD) Gets a Buy from Oppenheimer

Sui Ecosystem Token Sees Widespread Price Surge, CETUS Up 36% in 24 Hours

Gilead Q1 Biktarvy Sales $3.15 Bln

THOMSON REUTERS

Gilead Outlook 2025 EPS $5.65 - $6.05 VS Prior Guidance $5.95 - $6.35

THOMSON REUTERS

Gilead Q1 Total REV $6.67 Bln VS Ibes Estimate $6.81 Bln

THOMSON REUTERS

Gilead Q1 Veklury Sales $302 Mln

THOMSON REUTERS

Gilead Outlook 2025 Adj EPS, Product Sales Remains Unchanged

THOMSON REUTERS

Gilead Q1 Product Sales USD 6,613 Million

THOMSON REUTERS

Gilead Sciences Announces First Quarter 2025 Financial Results

THOMSON REUTERS

Gilead Sciences Announces First Quarter 2025 Financial Results

Harrow Authorizes Nordic Group Unit to sell Generic Version of Maxitrol eye Treatment

MT Newswires Live

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More

Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation

MT Newswires Live

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4578/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1327.2651,"timestamp":1745611199999,"preClose":1334.085,"halted":0,"volume":16469950,"delay":0,"changeRate":-0.005112,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-6.819824,"latestTime":"04-25 16:00:00 EDT","open":1339.4008,"high":1339.4756,"low":1309.7659,"amount":1710502491.303378,"amplitude":0.02227,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745847000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.46015,"peRate":19.501208,"turnoverRate":0.005384,"increases":1,"decrements":1,"flats":1,"marketCap":350142517408,"floatMarketCap":330854611176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1339.4756,"amplitude":0.02227,"preClose":1334.085,"low":1309.7659,"pbRate":"5.46015","latestPrice":1327.2651,"volume":16469950,"delay":0,"open":1339.4008,"prevYearClose":1164.883,"prevWeekClose":1327.2651,"prevMonthClose":1364.0579,"prevQuarterClose":1364.0579,"fiveDayClose":1323.6312,"twentyDayClose":1359.2554,"sixtyDayClose":1222.6431,"secType":"PLATE","market":"US","turnoverRate":0.005384,"peRate":19.501208,"marketCap":350142517408,"floatMarketCap":330854611176,"timestamp":1745611199999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":1,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530907164","title":"Sui Ecosystem Token Continues to Surge, WAL Surges Over 16% in 24 Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2530907164","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530907164?lang=en_us&edition=fundamental","pubTime":"2025-04-28 10:56","pubTimestamp":1745808960,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 28th, according to market data, the Sui ecosystem token continues to rise, including:WAL surged over 16% in the past 24 hours, now trading at $0.63;DEEP surged over 15% in the past 24 hours, now trading at $0.1996;BLUE surged over 13% in the past 24 hours, now trading at $0.1225;TURBOS surged over 9.5% in the past 24 hours, now trading at $0.00194.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/291484","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4211","LU1668664300.SGD","WAL","BK4589","BK4556","BK4585","LU1791807156.HKD","BK4139","BK4578","BK4588","BLUE","DEEP","LU0106831901.USD"],"gpt_icon":0},{"id":"2530643321","title":"US Health Secretary Reportedly Says 35 States to Join Pilot Program for Sickle Cell Disease Gene Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2530643321","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530643321?lang=en_us&edition=fundamental","pubTime":"2025-04-26 03:19","pubTimestamp":1745608779,"startTime":"0","endTime":"0","summary":"US Health and Human Services Secretary Robert Kennedy Jr. said 35 states will participate in a federal pilot program to expand access of costly gene therapies for sickle cell disease to Medicaid patients, multiple news outlets reported Friday.These 35 states house almost 84% of the Medicaid patients with the genetic blood disorder, Bloomberg reported, citing Kennedy's speech to the National Council of Insurance Legislators.The pilot program would also allow the Centers for Medicare and Medicaid Services to arrange payment agreements for the therapies on behalf of states, Bloomberg said.The various states' interest in the pilot program represents \"positive news\" for pharmaceutical companies that manufacture the gene therapies, including Bluebird Bio , Vertex Pharmaceuticals  and Crispr Therapeutics . The companies' therapies, which were approved in December 2023, come with a costly price tag and \"have struggled to gain traction,\" according to Bloomberg.The Department of Health and Human","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0417517546.SGD","LU1861559042.SGD","SG9999013999.USD","LU1585245621.USD","VRTX","SGXZ57979304.SGD","BK4556","LU2456880835.USD","LU1861558580.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU2236285917.USD","LU1093756168.USD","LU0823416689.USD","IE0002141913.USD","LU0256863811.USD","BLUE","BK4533","BK4567","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","CRSP","LU0289739699.SGD","IE00B894F039.SGD","BK4578","BK4139","LU0079474960.USD","LU0234570918.USD","LU0320765992.SGD","LU0058720904.USD","IE0002270589.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU2462157665.USD","SG9999001176.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0061475181.USD","LU1093756325.SGD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","LU2417539215.USD","LU1430594728.SGD","LU0889565916.HKD","LU1035775433.USD","IE00B19Z9P08.USD","BK4611"],"gpt_icon":0},{"id":"2530136072","title":"Gilead Shares Down 3.6% After Quarterly Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2530136072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530136072?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:32","pubTimestamp":1745587936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4N3R31CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0234570918.USD","BK4139","IE00BSNM7G36.USD","LU0289739699.SGD","BK4568","LU1839511570.USD","LU1585245621.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4588","IE00B19Z3581.USD","LU0058720904.USD","IE00B7SZLL34.SGD","BK4550","IE00B3T34201.USD","BK4585","BK4566","LU0889565916.HKD","BK4532","BK4578","GILD","BK4583","LU1066051498.USD","LU0109394709.USD","LU1066053197.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU1571399168.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU0320765992.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2530183726","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2530183726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530183726?lang=en_us&edition=fundamental","pubTime":"2025-04-25 18:52","pubTimestamp":1745578338,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD – Research Report), Merit Medi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-684?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-684?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3T34201.USD","LU0889565916.HKD","BK4137","LU1571399168.USD","LU0109394709.USD","IE0002270589.USD","LU0320765992.SGD","LU2468319806.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","BK4578","LU0289739699.SGD","LU1066051498.USD","BK4568","LU2089984988.USD","BK4139","GILD","HCSG","BK4550","LU2087621335.USD","BK4583","LU1430594728.SGD","IE00B19Z3581.USD","BK4566","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4585","LU1839511570.USD","IE00BKVL7J92.USD","LU1585245621.USD","BK4532","BK4588","LU1066053197.SGD","IE00BSNM7G36.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2530903420","title":"Gilead Shares Down 4.2% Premarket After Quarterly Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530903420?lang=en_us&edition=fundamental","pubTime":"2025-04-25 17:13","pubTimestamp":1745572426,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4N3R30Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4578","BK4532","BK4583","IE00B19Z3581.USD","LU2087621335.USD","IE00B3T34201.USD","LU0058720904.USD","BK4139","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1571399168.USD","BK4588","BK4550","LU0289739699.SGD","LU2468319806.SGD","LU0109394709.USD","BK4566","BK4585","IE00B7SZLL34.SGD","IE0002270589.USD","GILD","LU0889565916.HKD","LU0234570918.USD","LU2089984988.USD","LU1430594728.SGD","BK4568","LU1839511570.USD","LU1066053197.SGD","LU0320765992.SGD","LU1585245621.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2530527926","title":"Gilead : RBC Raises Target Price to $92 From $89","url":"https://stock-news.laohu8.com/highlight/detail?id=2530527926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530527926?lang=en_us&edition=fundamental","pubTime":"2025-04-25 13:37","pubTimestamp":1745559472,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R301W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0234570918.USD","LU1066051498.USD","LU2089984988.USD","BK4532","LU1839511570.USD","LU2087621335.USD","LU0058720904.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU1571399168.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4550","BK4583","IE00BKVL7J92.USD","LU0109394709.USD","LU0889565916.HKD","LU1585245621.USD","BK4578","LU1430594728.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","BK4566","IE00B3T34201.USD","BK4585","GILD","LU0320765992.SGD","BK4588","BK4568","LU2468319806.SGD"],"gpt_icon":0},{"id":"2530458942","title":"Gilead Sciences (GILD) Gets a Buy from Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530458942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530458942?lang=en_us&edition=fundamental","pubTime":"2025-04-25 11:55","pubTimestamp":1745553315,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Matthew Biegler from Oppenheimer maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","BK4566","LU0289739699.SGD","OPY","IE00BSNM7G36.USD","BK4583","GILD","IE00B19Z3581.USD","BK4578","LU0320765992.SGD","BK4568","LU1585245621.USD","LU0234570918.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4550","LU1430594728.SGD","LU2468319806.SGD","BK4139","LU1839511570.USD","LU0109394709.USD","LU1066053197.SGD","IE00B3T34201.USD","BK4532","LU1066051498.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4588","LU1571399168.USD","IE0002270589.USD","BK4127","LU0889565916.HKD","BK4585","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2530591728","title":"Sui Ecosystem Token Sees Widespread Price Surge, CETUS Up 36% in 24 Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2530591728","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530591728?lang=en_us&edition=fundamental","pubTime":"2025-04-25 09:29","pubTimestamp":1745544540,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 25th, according to CoinGecko data, the Sui ecosystem tokens saw a general price increase, including:CETUS rose by 36% in the past 24 hours, now trading at $0.191NS rose by 17.6% in the past 24 hours, now trading at $0.2261SEND rose by 34.5% in the past 24 hours, now trading at $0.6897NAVX rose by 18.7% in the past 24 hours, now trading at $0.06048BLUE rose by 14.6% in the past 24 hours, now trading at $0.08583SCA rose by 16.2% in the past 24 hours, now trading at $0.1161","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/291160","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4556","BLUE","BK4578","SCA","BK4139"],"gpt_icon":0},{"id":"2530960859","title":"Gilead Q1 Biktarvy Sales $3.15 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530960859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530960859?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","BK4532","LU1571399168.USD","IE00B3T34201.USD","LU0109394709.USD","LU0289739699.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","BK4588","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","BK4578","LU1066053197.SGD","GILD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU2468319806.SGD","LU2089984988.USD","BK4585","LU1066051498.USD","LU1839511570.USD","BK4583","LU0889565916.HKD","LU0058720904.USD","IE0002270589.USD","LU0234570918.USD","LU1430594728.SGD","BK4566","LU2087621335.USD","BK4550"],"gpt_icon":0},{"id":"2530608969","title":"Gilead Outlook 2025 EPS $5.65 - $6.05 VS Prior Guidance $5.95 - $6.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2530608969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530608969?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ1G4Q59.USD","LU0058720904.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0109394709.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4550","BK4588","LU0234570918.USD","LU1430594728.SGD","LU1066053197.SGD","LU2468319806.SGD","LU0320765992.SGD","BK4583","BK4585","LU2087621335.USD","LU1571399168.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1585245621.USD","BK4566","LU1839511570.USD","LU0889565916.HKD","BK4139","BK4578","BK4532","LU1066051498.USD","GILD","IE00BKVL7J92.USD","BK4568","LU2089984988.USD"],"gpt_icon":0},{"id":"2530396086","title":"Gilead Q1 Total REV $6.67 Bln VS Ibes Estimate $6.81 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530396086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530396086?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066051498.USD","BK4583","LU1571399168.USD","LU0234570918.USD","IE00B19Z3581.USD","LU0058720904.USD","LU2087621335.USD","IE0002270589.USD","IE00B3T34201.USD","BK4139","IE00BKVL7J92.USD","LU0109394709.USD","BK4568","IE00B19Z3B42.SGD","BK4550","BK4578","LU0289739699.SGD","IE00B7SZLL34.SGD","BK4585","GILD","IE00BSNM7G36.USD","BK4532","BK4566","LU0889565916.HKD","LU1430594728.SGD","LU1585245621.USD","LU1066053197.SGD","LU0320765992.SGD","LU1839511570.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","BK4588"],"gpt_icon":0},{"id":"2530196700","title":"Gilead Q1 Veklury Sales $302 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530196700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530196700?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3T34201.USD","LU0889565916.HKD","LU1571399168.USD","LU0109394709.USD","IE0002270589.USD","LU0320765992.SGD","LU2468319806.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","BK4578","LU0289739699.SGD","LU1066051498.USD","BK4568","LU2089984988.USD","BK4139","GILD","BK4550","LU2087621335.USD","BK4583","LU1430594728.SGD","IE00B19Z3581.USD","BK4566","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4585","LU1839511570.USD","IE00BKVL7J92.USD","LU1585245621.USD","BK4532","BK4588","LU1066053197.SGD","IE00BSNM7G36.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2530071967","title":"Gilead Outlook 2025 Adj EPS, Product Sales Remains Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2530071967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530071967?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU0289739699.SGD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4139","LU1066053197.SGD","LU1430594728.SGD","BK4568","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1839511570.USD","BK4583","IE00B19Z3B42.SGD","LU1571399168.USD","LU0889565916.HKD","LU1585245621.USD","BK4585","LU0234570918.USD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","IE0002270589.USD","LU1066051498.USD","LU0320765992.SGD","LU2087621335.USD","BK4578","BK4588","BK4566","LU0109394709.USD","GILD","IE00B19Z3581.USD","BK4550","LU0058720904.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2530880960","title":"Gilead Q1 Product Sales USD 6,613 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2530880960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530880960?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nPLX7136FF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4583","BK4532","LU2089984988.USD","IE00BKVL7J92.USD","LU1430594728.SGD","BK4585","LU1839511570.USD","LU2468319806.SGD","BK4139","LU1066051498.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","BK4568","LU0320765992.SGD","IE00B19Z3581.USD","BK4578","LU1066053197.SGD","LU0889565916.HKD","LU1571399168.USD","LU0234570918.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","GILD","IE00B3T34201.USD","LU0109394709.USD","LU2087621335.USD","BK4588","BK4550"],"gpt_icon":0},{"id":"2530496707","title":"Gilead Sciences Announces First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2530496707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530496707?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA5YJYJY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B7SZLL34.SGD","BK4566","LU0289739699.SGD","IE00BSNM7G36.USD","BK4583","GILD","IE00B19Z3581.USD","BK4578","LU0320765992.SGD","BK4568","LU1585245621.USD","LU0234570918.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4550","LU1430594728.SGD","LU2468319806.SGD","BK4139","LU1839511570.USD","LU0109394709.USD","LU1066053197.SGD","IE00B3T34201.USD","BK4532","LU1066051498.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4588","LU1571399168.USD","IE0002270589.USD","LU0889565916.HKD","BK4585","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2530186996","title":"Gilead Sciences Announces First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2530186996","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530186996?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524920,"startTime":"0","endTime":"0","summary":"Product Sales Excluding Veklury Increased 4% Year-Over-Year to $6.3 billion. Biktarvy Sales Increased 7% Year-Over-Year to $3.1 billion. FOSTER CITY, Calif., April 24, 2025----Gilead Sciences, Inc.  announced today its first quarter 2025 results of operations.\"Gilead had a strong start to the year driven by excellent commercial and clinical execution along with disciplined expense management,\" said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. \"Our base business grew 4% year-over-year, primarily led by Biktarvy’s continued strength, and we announced positive topline Phase 3 results for Trodelvy plus pembrolizumab in first line PD-L1+ metastatic triple negative breast cancer. With the upcoming June PDUFA date for lenacapavir for HIV prevention, and continued progress across our diverse pipeline, we look forward to building on our positive momentum throughout the year.\". As of March 31, 2025, Gilead had $7.9 billion of cash and cash equivalents compared to $10.0 billion as","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-announces-first-quarter-200200808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU0889565916.HKD","LU0109394709.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU0289739699.SGD","BK4139","BK4568","LU1066051498.USD","IE00B19Z3581.USD","LU2468319806.SGD","BK4578","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00B3T34201.USD","IE0002270589.USD","LU0320765992.SGD","BK4588","LU0058720904.USD","BK4583","LU0234570918.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2087621335.USD","BK4532","BK4550","LU1585245621.USD","LU1839511570.USD","BK4566","LU1066053197.SGD","IE00BSNM7G36.USD","BK4585","GILD"],"gpt_icon":0},{"id":"2530495238","title":"Harrow Authorizes Nordic Group Unit to sell Generic Version of Maxitrol eye Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2530495238","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530495238?lang=en_us&edition=fundamental","pubTime":"2025-04-25 00:00","pubTimestamp":1745510403,"startTime":"0","endTime":"0","summary":"Harrow (HROW) is partnering with a subsidiary of privately held Nordic Group for the launch of an authorized generic of Maxitrol ophthalmic suspension to treat bacterial eye infections.Financial terms","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4007","IE00BFTCPJ56.SGD","HROW","LU0211331839.USD","LU0320765489.SGD","LU0208291251.USD","IE0002141913.USD","BK4585","LU0070302665.USD","IE00B2B36J28.USD","BK4588","BK6520","IE0009355771.USD","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK6045","NVS","MR7.SI","BK4557"],"gpt_icon":0},{"id":"2529617659","title":"Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2529617659","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529617659?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:37","pubTimestamp":1745426220,"startTime":"0","endTime":"0","summary":"This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol Myers Squibb BMY was down on data from the schizophrenia study while Regeneron REGN was in the spotlight on updates on key drugs.Bristol Myers announced disappointing top-line results from the phase III ARISE study on schizophrenia drug Cobenfy . The study is evaluating the efficacy and safety of Cobenfy as an adjunctive treatment to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia.Treatment with Cobenfy as an adjunctive demonstrated a 2.0-point reduction in the Positive and Negative Syndrome Scale total score compared to placebo with an atypical antipsychotic at week six. However, this data did not reach the threshold for statistical significance for the primary endpoint. Shares of BMY were down following the data announcement.Preliminary analyses suggest that Cobenfy as an adjunctive treatment to an atypical antipsychotic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-bmy-down-163700964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4559","LU1291159041.SGD","IE00B3T34201.USD","REGN","IE00BJJMRZ35.SGD","LU1670711040.USD","BK4585","IE00B7SZLL34.SGD","BK4578","LU0058720904.USD","BK4007","CRL","IE0002141913.USD","LU1670710588.SGD","LU1989771016.USD","LU0868494617.USD","BMY","LU0306807586.USD","LU1093756168.USD","LU1670710661.SGD","LU1868837300.USD","SNY","LU2362541513.USD","IE00BKVL7J92.USD","LU1430594728.SGD","LU0889565916.HKD","LU0225771236.USD","BK4583","BK4532","LU0306806265.USD","LU1868836914.USD","LU2089984988.USD","LU2023250504.SGD","LU1093756325.SGD","LU2133065610.SGD","LU0289739699.SGD","LU0320765992.SGD","LU2237438978.USD","LU2362541273.HKD","PFS","IE00B19Z3B42.SGD","LU0053666078.USD","BK4097","IE0002270589.USD","LU0234570918.USD","GILD","OS","LU0225284248.USD","LU1839511570.USD","LU1670711123.USD"],"gpt_icon":0},{"id":"2529682519","title":"Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682519","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529682519?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:56","pubTimestamp":1745416573,"startTime":"0","endTime":"0","summary":"Novartis  Chief Executive Vas Narasimhan and Paul Hudson, his counterpart at Sanofi  said Wednesday that EU \"price controls and austerity measures\" are decreasing the bloc's attractiveness for pharmaceutical companies.In a letter to the Financial Times, Narasimhan and Hudson said that the US and China are trying to boost innovation, while in Europe \"launch prices are suppressed, patented medicines' growth capped, and prices reduced when new applications are found.\"\"We see a strong outlook for the US -- thanks to policies and regulations conducive to fast and broad patient access to innovative medicines. Unfortunately, this cannot be said for Europe,\" the CEOs said.\"Against a backdrop of waning European biopharma competitiveness, the uncertainty of tariffs is further reducing incentives to invest in the EU,\" the letter said.\"Europe has leading universities, talent and hospitals. With deregulation and an attractive market for innovation, it can succeed. However, it must act decisively an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","BK4588","SNY","IE00BJJMRZ35.SGD","IE0009355771.USD","SNYNF","NVS","LU0211331839.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4007","HUDAU","LU0070302665.USD","IE00BFTCPJ56.SGD","BK4156","IE00BFXG1179.USD","LU0208291251.USD","BK4532","IE00B2B36J28.USD","IE0002141913.USD","BK4585","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2529322566","title":"Why Novartis (NVS) is a Top Momentum Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2529322566","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529322566?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:50","pubTimestamp":1745416203,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Is This 1 Momentum Stock a Screaming Buy Right Now?Different than value or growth investors, momentum-oriented investors live by the saying \"the trend is your friend.\" This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.This article originally published on Zacks Investment Research ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-novartis-nvs-top-momentum-135003110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","IE0002141913.USD","BK4578","NVS","BK4007","BK4588","IE00B4R5TH58.HKD","LU0208291251.USD","BK4532","IE0009355771.USD","LU0070302665.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}